Loading...
XSHE002258
Market cap862mUSD
Jan 10, Last price  
7.90CNY
1D
-1.99%
1Q
-1.86%
Jan 2017
-11.04%
IPO
22.67%
Name

Lier Chemical Co Ltd

Chart & Performance

D1W1MN
XSHE:002258 chart
P/E
10.47
P/S
0.81
EPS
0.75
Div Yield, %
7.00%
Shrs. gr., 5y
1.20%
Rev. gr., 5y
14.28%
Revenues
7.85b
-22.55%
172,574,599262,803,447304,019,433403,999,580394,209,552445,312,819936,008,3871,278,092,6281,440,423,0461,317,389,5511,489,071,4851,982,302,5983,083,547,8914,027,069,3394,163,842,1244,968,747,8236,494,251,25610,136,144,2237,850,607,495
Net income
604m
-66.68%
57,366,12699,440,361107,022,37587,675,709101,153,25871,738,07569,621,90887,621,131104,088,60292,412,057138,453,579208,347,320401,967,285577,810,917311,142,625612,208,8731,072,386,6321,812,519,445603,888,241
CFO
939m
-63.85%
38,078,25853,541,25489,843,36931,800,197127,541,20482,482,17540,146,709103,306,903108,899,371140,335,346156,796,906184,861,778362,985,774348,038,821589,723,367899,001,3641,317,229,8942,596,557,328938,573,493
Dividend
Apr 20, 20230.5 CNY/sh
Earnings
Apr 11, 2025

Profile

Lier Chemical Co.,LTD. engages in the research and development, production, and sale of agrochemical products in the People's Republic of China and internationally. The company offers low-toxicity and low-residue safe pesticides, such as chloropyridines and organophosphates. It also provides herbicides, including pinoxaden, glufosinate-ammonium, diquat, flumioxazin, clodinafop-propargyl, clopyralid acid, picloram, fluroxypyr-meptyl, triclopyr, diuron, bensulfuron-methyl, linuron, pyrazosulfuron-ethyl, nicosulfuron, flufenacet, mefenacet, and quinclorac; fungicides, such as azoxystrobin, epoxiconazole, iprodione, and difenoconazole; and insecticides comprising chlorpyrifos and pyriproxyfen, as well as active pharmaceutical ingredients and preparations. In addition, the company offers chemical intermediates, including 2-chloropyridine; 2,3-dichloropyridine; 2,5-dichloropyridine; 2,6-dichloropyridine; 2,3,4-trichloropyridine; 2,3,5-trichloropyridine; 2,3,6-trichloropyridine; nitrapyrin; pentafluoropyridine; 2,3,5,6-tetrachloro-4-methylsulfonylpyridine; 6-chloropyridine-2-carbonitrile; 3,6-difluoropyridine-2-carboxylic acid; 2,2'-bipyridine; 2-chloro-4'-fluoroacetophenone; 2-chloro-2',4'-difluoroacetophenone; and 2-fluoro-3-nitrobenzoic acid. Further, its intermediates comprise (E)-4-(dimethylamino)but-2-enoic acid hydrochloride; 4,4'-dichloro-[3,3']bipyridinyl; clopyralid-methyl; methyl 3,4,6-trichloropicolinate; 2,4,5-trichloropyridine; 7-fluoro-6-nitro-4-hydroxyquinazoline; N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine; 4-bromocrotonic acid; 4-N-(3-chloro-4-fluorophenyl)-7-[(3S)-oxolan-3-yl]oxyquinazoline-4,6-diamine; 2-amino-N-(2-chloro-6-methylphenyl)-1,3-thiazole-5-carboxamide; and 5-chloro-8-hydroxyquinoline. Lier Chemical Co.,LTD. was founded in 1993 and is headquartered in Mianyang, the People's Republic of China.
IPO date
Jul 08, 2008
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
7,850,607
-22.55%
10,136,144
56.08%
Cost of revenue
6,656,168
7,481,206
Unusual Expense (Income)
NOPBT
1,194,440
2,654,938
NOPBT Margin
15.21%
26.19%
Operating Taxes
109,917
341,885
Tax Rate
9.20%
12.88%
NOPAT
1,084,523
2,313,053
Net income
603,888
-66.68%
1,812,519
69.02%
Dividends
(442,669)
(264,272)
Dividend yield
4.62%
1.84%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
240,110
603,312
Long-term debt
2,097,210
581,848
Deferred revenue
265,122
207,584
Other long-term liabilities
28,091
58,334
Net debt
872,503
(223,905)
Cash flow
Cash from operating activities
938,573
2,596,557
CAPEX
(1,972,110)
Cash from investing activities
(1,918,346)
Cash from financing activities
1,018,278
FCF
(589,509)
1,178,174
Balance
Cash
1,464,760
1,409,069
Long term investments
57
(4)
Excess cash
1,072,286
902,258
Stockholders' equity
7,240,371
6,872,778
Invested Capital
10,297,712
8,792,436
ROIC
11.36%
29.52%
ROCE
10.43%
27.25%
EV
Common stock shares outstanding
800,488
800,437
Price
11.97
-33.35%
17.96
-25.45%
Market cap
9,581,843
-33.35%
14,375,853
-22.61%
EV
11,709,609
15,265,289
EBITDA
1,823,877
3,220,482
EV/EBITDA
6.42
4.74
Interest
52,236
65,965
Interest/NOPBT
4.37%
2.48%